SCHEMBL6989339

SCHEMBL6989339

CCCC[N+]1(OC(=O)C(F)(F)F)CCSc2sc(C(=N)N)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6989334 0.67 NOS3 (0.31)
SCHEMBL16701138 0.59 FAAH (0.35)
SCHEMBL6996056 0.57 KCNN4 (0.30)
SCHEMBL16700592 0.55 FAAH (0.40)
SCHEMBL15158325 0.54 CES2 (0.33)
SCHEMBL4246323 0.54
SCHEMBL2267527 0.53 CHRM2 (0.30)
SCHEMBL29368262 0.51 FAAH (0.41)
SCHEMBL2265540 0.49 CHRM2 (0.31)
Heptane SCHEMBL7045881 0.49 FAAH (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927177-B1 NOVEL BENZOTHIOPHENE DERIVATIVES, THEIR PREPARATION AND USE AS UROKINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-26 EP disclosed
US-6093710-A AN ENZYME INHIBITOR TREATING ANGIOGENESIS, ARTHRITIS, INFLAMMATION, METASTASIS, OSTEOPOROSIS, TUMORSANGIOGENESIS-DEPENDENT RETINOPATHIES, CONTRACEPTIVE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-25 US disclosed